Target intelligence / Profile preview

Feline allergen Fel d 4 (Fel d 4)

Target
Fel d 4
Molecular classification
Lipocalin, Allergen, Transport protein
01

Overview

Fel d 4 is a major feline allergen belonging to the lipocalin family of proteins, primarily produced in the submandibular salivary glands and deposited on cat fur through grooming. It is the second most prevalent cat allergen after Fel d 1, with over 60% of cat-allergic individuals showing sensitization to this specific protein. Structurally, Fel d 4 functions as a transport protein for small hydrophobic molecules, such as pheromones, which may play a role in chemical signaling between animals. In humans, Fel d 4 acts as a potent trigger for Type I hypersensitivity reactions, where it cross-links IgE antibodies on the surface of mast cells and basophils, leading to the release of inflammatory mediators. This process results in clinical symptoms ranging from allergic rhinitis and conjunctivitis to severe bronchial asthma. In the context of therapeutics, Fel d 4 is a primary component in allergen-specific immunotherapy (AIT) formulations and is a critical target for component-resolved diagnostics (CRD) to differentiate between primary cat sensitization and cross-reactivity with other animal lipocalins.

Other names
Major cat allergen Fel d 4Felis domesticus allergen 4Lipocalin allergen Fel d 4Salivary lipocalin
02

Mechanism of action

Allergen immunotherapy (AIT) involves the administration of gradually increasing doses of the allergen to induce peripheral T-cell tolerance, increase regulatory T-cells (Tregs), and shift the immune response from a Th2 to a Th1 profile, thereby reducing IgE-mediated mast cell degranulation.

03

Biological functions

Lipid transportPheromone bindingImmune response induction
04

Disease associations

Allergic rhinitisAsthmaAtopic dermatitisType I hypersensitivity
05

Safety considerations

AnaphylaxisLocal injection site reactionsSystemic allergic reactionsExacerbation of asthma
06

Interacting drugs

Allergen extract Felis catus

1 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Fel d 4Specific IgG4 (sIgG4) to Fel d 4Basophil activation test (BAT)

Beyond the preview

Go deeper on Feline allergen Fel d 4 (Fel d 4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feline allergen Fel d 4 (Fel d 4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call